High expression of SEMA4C transcripts was associated with relative cancer aggression, as evidenced by shorter survival in an analysis of 1402 breast cancer patients from The Cancer Genome Atlas (TCGA) cohort. Here, SEMA4C is linked to breast carcinoma.